Pulmonary Embolism

FDA Clears AlphaVac F1885 System for Treatment of Pulmonary Embolism

The clearance broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature.

Pulmonary Embolism

Short Sleep Tied to Increased Risk of Peripheral Artery Disease

Sleeping less than five hours a night is associated with a 74% raised likelihood of developing peripheral artery disease (PAD) compared with seven to eight hours of sleep.

Pulmonary Embolism

‘Rogue Antibodies’ Involved in Severe COVID-19 Blood Clots

Circulating antiphospholipid antibodies which target a person’s own organs and systems, can also be activated in response to viral infections and may play a role with COVID-19 blood clots.

Clinical Trial for Endovascular System Begins

by RT Staff | Aug 12, 2021 | Clinical Trials, Pulmonary Embolism, Therapy Devices | 0

Boston Scientific has begun enrollment in a clinical trial comparing use of the EkoSonic Endovascular System (EKOS) in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk pulmonary embolism.

Management of Acute Pulmonary Embolism

by RT Staff | Apr 25, 2021 | Critical Care, Pulmonary Embolism | 0

Only a small percentage of hospitalized patients with acute pulmonary embolism are discharged home from the emergency department, according to new research in the Academic Emergency Medicine journal.

COVID-19 Patients Treated for Blood Clots Showed Rapid Improvement

by RT Staff | Apr 15, 2020 | Coronavirus, Pulmonary Embolism | 0

A small study of five patients with COVID-19 found that treatment with tPA — a thrombolyic agent used to dissolve blood clots — resulted in rapid improvement in alveolar ventilation, oxygenation, and/or shock.

First Eliquis Generics Approved for DVT, Pulmonary Embolism

by RT Staff | Jan 8, 2020 | Business News, Cardiopulmonary & Thoracic, FDA Approvals, Pulmonary Embolism, US Pharmaceuticals | 0

The first two generics of Eliquis (apixaban) have been approved for cardiopulmonary conditions, including deep vein thrombosis and pulmonary embolism.

These Six Surgeries Have Elevated Post-op Pulmonary Embolism Risk

by RT Staff | Oct 19, 2019 | Pulmonary Embolism | 0

The postoperative risk for pulmonary embolism extends more than six weeks for six types of...

Smokers Have Higher Rehospitalization Rates for Pulmonary Emboli

by RT Staff | Oct 16, 2019 | Pulmonary Embolism, Smoking, Tobacco | 0

Smokers with pulmonary emboli are more likely to be readmitted for PE than nonsmokers, according to research at Chest 2019 in New Orleans.

Better Guidelines Needed for Diagnosing PE during Pregnancy

by RT Staff | Mar 13, 2019 | Pulmonary Embolism | 0

Despite low incidence, pulmonary embolism is one of the leading causes of maternal mortality, with several challenges to proper diagnosis.

In ER, Pulmonary Embolism Causes Less than 1% of Syncope

by RT Staff | Feb 23, 2018 | Pulmonary Embolism | 0

Pulmonary embolism was responsible for syncope in just 0.06% to 0.55% of patients treatd in emergency rooms, according to a JAMA Internal Medicine study.

Another NBA Player Sidelined by Pulmonary Embolism

by RT Staff | Dec 18, 2017 | Pulmonary Embolism | 0

Mirza Teletovic, a forward for the NBA’s Milwaukee Bucks, has been diagnosed with pulmonary embolism in both lungs and will be out of action as a result.

Apple Watch Alerts Man to Pulmonary Embolism

by RT Staff | Oct 16, 2017 | Pulmonary Embolism | 0

According to James Green from Brooklyn, NY, his Apple Watch was able to alert him to an elevated heart rate which was the start of a pulmonary embolism.